Eileen D. Brewer, MD is an internationally known expert in pediatric kidney disease, dialysis, transplantation and hypertension. She currently is Professor of Pediatrics and former Head of the Pediatric Renal Section at Baylor College of Medicine. Dr. Brewer is known for her pioneering work on adapting peritoneal and hemodialysis for children. She has been the medical director of pediatric dialysis units at two institutions and is currently the medical director of kidney transplant at Texas Children’s Hospital in Houston, which is now one of the largest pediatric kidney transplant programs in the nation. Dr. Brewer’s clinical research career has focused on children with rare renal tubular disorders, kidney bone and mineral disorders and end stage kidney disease, including participation in many multicenter clinical trials. Dr. Brewer has been recognized nationally for her advocacy for children with kidney disease and her contributions to service in the field of nephrology. She has served and continues to be active on many committees of national medical organizations focused on public policy and healthcare payment. She is the current Chair of the AAP Committee on Coding and Nomenclature and the AAP alternate representative to the AMA Relative Value Update Committee. Additionally, she was a co-Chair of a seminal NIH Task Force on chronic kidney disease in children in 2002 and has served on multiple CMS technical expert panels for pediatric quality and payment for end stage kidney disease. Dr. Brewer has been a tireless and effective advocate for children with kidney disease at CMS and with public officials on Capitol Hill, working with both the American Society of Pediatric Nephrology (ASPN) and the Renal Physicians Association. She is past president of the ASPN and long-time member and past chair of the ASPN Public Policy Committee. In the last 15 years, she was active with OPTN/UNOS as committee member, committee chair and board member, ensuring that pediatrics is represented and has priority in the national transplant system. Dr. Brewer is a recipient of the ASPN Founder’s Award for unique and lasting contributions to Pediatric Nephrology, the Baylor College of Medicine Master Clinician Award for faculty contributions to patient care, and the AAP Henry L. Barnett Award for lifetime achievement in pediatric nephrology for teaching, clinical care and advocacy.
- Define advocacy and know why advocacy is important for improving healthcare quality and availability for children.
- Identify key steps toward becoming an advocate for pediatrics.
- Recognize opportunities to start advocating for pediatric healthcare.
This seminar was delivered as a Pediatric Grand Rounds Lecture at Children’s Hospital of Philadelphia, on February 15, 2023.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.